Banerjee T, Mitra S Singh AK, Sharma RK, Maitra A Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. International Journal of Pharmaceutics, (1-2) 93-105 (2002)
1.1
Min-Lang Tsai, Rong-Huei Chen, Shi-Wei Bai and Wei-Yu Chen. The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer. Carbohydrate Polymers 2011;84(2): 756-761
1.2
Jasjeet Kaur Sahni, Sihem Doggui, Javed Ali, Sanjula Baboota, Lé Dao and Charles Ramassamy. Neurotherapeutic applications of nanoparticles in Alzheimer's disease. doi:10.1016/j.jconrel.2010.11.033.
1.3
B, Samanta MK, Santhi K, Kumar KP, Ramasamy M, Suresh B. Nanomedicine. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Wilson 2010 6(1):144-52.
1.4
Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010 31;62(1):3-11.
1.5
Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of thenanoparticle protein corona. ACS Nano. 2010 27;4(7):3623-32.
1.6
Devarajan PV, Jindal AB, Patil RR, Mulla F, Gaikwad RV, Samad A. Particle shape: a new design parameter for passive targeting in splenotropic drug delivery. J Pharm Sci. 2010 99(6):2576-81.
1.7
Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, Wang CH, Yuan Z, Liu M, Wan HY, Tang H. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials. 2010 31(17):4748-56.
1.19
Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Advanced Drug Delivery Reviews 2010 62 (1): 3-11
1.10
Cheng MH 2010 Current Appli Phy 2010. 10: 797
1.11
Wang Q Nanomed-Nanotechlol Biol Med 2010. 6 : 371
1.12
Nakamura M Adv Sci Lett 2010. 3: 130
1.13
Sundar S Sci Technol Adv Matter 2010. 11: 014104
1.14
Abreu Foms. Express Polym Lett 2010. 4: 456
1.15
Wang JQ. Biomaterials Curr Drug M etab 2010. 11:129
1.16
Johnston AH. J Nanopart Res 2010. 12: 1997
1.17
Manchanda R. J Appl Polym Sci 2010. 118: 2071
1.18
Loh JW, Schneider J, Carter M, Martin Saunder M, Lim Lee-Yong. Spinning disc processing technology: Potential for large-scale manufacture of chitosan nanoparticles. J. Pharm Sci. (In press)
1.19
Xiaolin T, Dafeng T, Zhongyan W, Mo Fengku Mo. Synthesis and evaluation of chitosan-vitamin C complexes. J. App. Polymer Sci. 114 (5): 2986-2991 (2009)
1.20
Ravi Kumar M.N.V, Hudson S. M. Chitosan. Encyclopedia of Biomaterials and Biomedical Engineering. Informa Health Care. Published on 31st August, 2004.
1.21
Tian Xiaolin, Tian Dafeng, Wang Zhongyan, Mo Fengkui. Synthesis and evaluation of chitosan-vitamin C complexes. Journal of Applied Polymer Science 114; 2986 – 2991.
1.22
T. Keana and M. Thanoub. Biodegradation, biodistribution and toxicity of chitosan. Advanced Drug Delivery Reviews 62; 3-11 (2010).
1.23
Boonsongrit Y. Chitosan drug binding by Ionic Interactions : Preparation, Characterization and In vitro release study. Faculty of Graduate Studies (Mahidol University), 2006.
1.24
XL Tian, DF Tian, ZY Wang, FK Mo. Synthesis and evaluation of chitosan-Vitamin C complex. Indian J Pharmaceutical Science 71; 371-376 (2009).
1.25
Omid Veiseh, Jonathan W. Gunn and Miqin Zhang. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Advanced Drug Delivery Reviews
62; 284-304 (2010).
1.26
Sperling RA, Casals E, Comenge J, Bastus NG, Puntes VF. Inorganic Engineered Nanoparticles and Their Impact on the Immune Response. Current Drug Metabolism 10: pp. 895-904 (2009).
1.27
Qin Tian, Chuang-Nian Zhang, Xiu-Hua Wang, Wei Wang, Wei Huang, Rui-Tao Cha, Chun-Hong Wang, Zhi Yuan, Min Liu, Hai-Ying Wan and Hua Tang. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 31; 4748-4756 (2010).
1.28
Wang, Jianqiu; Sui, Meihua; Fan, Weimin. Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics. Current Drug Metabolism, 11; 129-141(13) [2010].
1.29
Kowapradit J, Opanasopit P, Ngawhirunpat T, Rojanrata T, Ruktanonchai U, Sajomsang W. Methylated N- (4 N,N –demethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells. Drug Delivery 2010 (Published online).
1.30
Sushmitha Sundar et al. Biopolymeric nanomaterial. Science and Technology of Advance Materials. 11; 014104 (2010).
1.31
Mu-hua Chenga, Yao-xiong Huang, Han-jian Zhou, Zhi Liu and Jian-fang Li. Rapid preparation and characterization of chitosan nanoparticles for oligonucleotide. Current Applied Physics
10; 797-800 (2010).
1.32
AH Johnston, PD Dalton, TA Newman Polymersomes, smaller than you think: ferrocene as a TEM probe to determine … Journal of Nanoparticle Research-, 2010 (in press)
1.33
Padma V. Devarajan, Anil B. Jindal, Rajesh R. Patil, Fernaz Mulla, Rajiv V. Gaikwad, Abdul Samad. Particle shape: A new design parameter for passive targeting in splenotropic drug delivery. J. Pharmaceutical Sc.99; 2576-2581.
1.34
Z Hou, Q Sun, Q Wang, J Han, Y Wang, Q Zhang (2009). In vitro and in vivo evaluation of novel implantable collagen-chitosan-soybean phosphatidylcholine composite film for the sustained delivery of mitomycin C. Drug Development Research. Volume 9999 Issue 9999 (Published online on 20th April, 2009).
1.35
X Cheng, F Zhang, G Zhou, S Gao, L Dong, W Jiang. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin. Drug Delivery, 2009 - Informa Pharma Science.
1.36
Tan ML Choong, PFM Dass, CR Cancer, chitosan nanopartides and catalytic nucleic acids Journal of Pharmacy and Pharmacology 61 (1), pp. 3-12 (2009)
1.37
Duan Y, Xu J, Lin Y, Yu H, Gong T, Li Y, Zhang Z, A preliminary 1.37study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers Journal of Biomedical Materials Research - Part A 87 (2), pp. 515-523 (2008)
1.38
Brunel F, Véron L, David L, Domard A, Delair T. A novel synthesis of chitosan nanoparticles in reverse emulsion Langmuir 24 (20), pp. 11370-11377 (2008)
1.39
Mincheva R, Bougard F, Paneva D, Vachaudez M, Manolova N, Dubois P, Rashkov, I. Self-assembly of N-carboxyethylchitosan near the isoelectric point Journal of Polymer Science, Part A: Polymer Chemistry 46 (20), pp. 6712-6721 (2008)
1.40
Sonavane G, Tomoda K, Makino K, Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size Colloids and Surfaces B: Biointerfaces 66 (2), pp. 274-280 (2008)
1.41
Wu G, He X-L, Zhang H-L, Li S-J, Liu L-X, Du G-H, Leng X-G,
Effect of chitosan gene nanoparticles on L02 cells Acta Academiae Medicinae Sinicae 30 (5), pp. 574-577 (2008)
1.42
Zhao Y-B, Qiu Z-M, Liu Z-W, Huang J-Y, Preparation and characteristics of composite magnetic chitosan microspheres used as carrier of targeted-drug Cailiao Gongcheng/Journal of Materials Engineering (10), pp. 358-362 (2008)
1.43
Wilson B, Samanta MK, Santhi K, Kumar KPS, Paramakrishnan N, Suresh B, Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles European Journal of Pharmaceutics and Biopharmaceutics 70 (1), pp. 75-84 (2008)
1.44
Hu B, Pan C, Sun Y, Hou Z, Ye H, Hu B, Zeng X, Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins Journal of Agricultural and Food Chemistry 56 (16), pp. 7451-7458 (2008)
1.45
Seal BL, Lien Y-HH, Mazar C, Salkini MW, Cai T, Hu Z, Marquez M, Garcia AA, Method for tracking nanogel particles in vivo and in vitro Biotechnology Journal 3 (7), pp. 954-958 (2008)
1.46
Jain D, Banerjee R, Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery Journal of Biomedical Materials Research - Part B Applied Biomaterials 86 (1), pp. 105-112 (2008)
1.47
Gaunet M, Vargas A, Gurny R, Delie F, Nanoparticles for drug delivery: The need for precision in reporting particle size parameters European Journal of Pharmaceutics and Biopharmaceutics 69 (1), pp. 1-9 3 (2008)
1.48
Ma W-j, Yuan X-b, Kang C-s, Su T, Yuan X-y, Pu P-y, Sheng J, Evaluation of blood circulation of polysaccharide surface-decorated PLA nanoparticles Carbohydrate Polymers 72 (1), pp. 75-81 (2008)
1.49
Wilson B, Samanta MK, Santhi K, Kumar KPS, Paramakrishnan N, Suresh B, Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease Brain Research 1200 (C), pp. 159-168 (2008)
1.50
Sikarwar MS, Sharma S, Jain AK, Parial SD. Preparation, characterization and evaluation of Marsupsin-phospholipid complex AAPS PharmSciTech 9 (1), pp. 129-137 (2008)
1.51
Yoksan R, Chirachanchai S, Amphiphilic chitosan nanosphere: Studies on formation, toxicity, and guest molecule incorporation Bioorganic and Medicinal Chemistry 16 (5), pp. 2687-2696 (2008)
1.51
Yuan X-B, Yuan Y-B, Jiang W, Liu J, Tian E-J, Shun H-M, Huang D-H, (...), Sheng J, Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation International Journal of Pharmaceutics 349 (1-2), pp. 241-248 (2008)
1.52
Tsai ML, Bai SW, Chen RH, Cavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticle Carbohydrate Polymers 71 (3), pp. 448-457 (2008)
1.53
Long D, Wu G, Zhu G, Noncovalently modified carbon nanotubes with carboxymethylated chitosan: A controllable donor-acceptor nanohybrid International Journal of Molecular Sciences 9 (2), pp. 120-130 (2008)
1.54
Podsiadlo P, Sinani VA, Bahng JH, Kam NWS, Lee J, Kotov NA Gold nanoparticles enhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent Langmuir 24 (2), pp. 568-574 (2008)
1.55
Liu H, Chen B, Mao Z, Gao C, Chitosan nanoparticles for loading of toothpaste actives and adhesion on tooth analogs Journal of Applied Polymer Science 106 (6), pp. 4248-4256 (2007)
1.56
Hao L, Li S, Han L, Huang J, Chang J, Preparation and Characterization of a Novel Magnetic Nano-Gene Vector Acta Physico - Chimica Sinica 23 (12), pp. 1857-1863 (2007)
1.57
Pulliam B, Sung JC, Edwards DA Design of nanoparticle-based dry powder pulmonary vaccines Expert Opinion on Drug Delivery 4 (6), pp. 651-663 (2007)
1.58
Zhou S-H, Chen Y, Hong Y, Biological effect of chitosan nanoparticles Journal of Clinical Rehabilitative Tissue Engineering Research 11 (26), pp. 5190-5193 (2007)
1.59
Shuangyan L, Lijuan H, Yong Y, Lei H, Peng Y, Jie H, Jin C, Synthesis and characterization of lysine modified chitosan magnetic microspheres - A novel gene delivery system Proceedings of the International Conference on Integration and Commercialization of Micro and Nanosystems 2007 A, pp. 357-366 (2007)
1.60
Zhang L, Kosaraju SL, Biopolymeric delivery system for controlled release of polyphenolic antioxidants European Polymer Journal 43 (7), pp. 2956-2966
1.61
Cao W-J, Cheng J, Wang C-G, (2007) Novel materials as vehicles for target drug delivery system Journal of Clinical Rehabilitative Tissue Engineering Research 11 (22), pp. 4380-4383 (2007)
1.62
Wang C, Fu X, Yang L, Water-soluble chitosan nanoparticles as a novel carrier system for protein delivery Chinese Science Bulletin 52 (7), pp. 883-889 (2007)
1.62
Boucard N, David L, Rochas C, Montembault A, Viton C, Domard A, Polyelectrolyte microstructure in chitosan aqueous and alcohol solutions Biomacromolecules 8 (4), pp. 1209-1217 (2007)
1.63
Mitra A, Nan A, Line BR, Ghandehari H, Nanocarriers for nuclear imaging and radiotherapy of cancer Current Pharmaceutical Design 12 (36), pp. 4729-4749 (2006)
1.64
Borato CE, Leite FL, Mattoso LHC, Goy RC, Campana Filho SP, De Vasconcelos CL, Da Trindade Neto CG, (...), Oliveira Jr, ON Layer-by-layer films of poly(o-ethoxyaniline), chitosan and chitosan-poly(methacrylic acid) nanoparticles and their application in an electronic tongue IEEE Transactions on Dielectrics and Electrical Insulation 13 (5), art. no. 1714936, pp. 1101-1109 (2006)
1.65
Shen L-F, Wang X, Wang C, Zhao K, Liu X-J, Shen H-J, Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting Journal of Central South University (Medical Sciences) 31 (5), pp. 732-736+741 (2006)
1.66
Chavanpatil MD, Khdair A, Panyam J, Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery Journal of Nanoscience and Nanotechnology 6 (9-10), pp. 2651-2663 (2006)
1.67
Yuan X-b, Li H, Yuan Y-b, Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface Carbohydrate Polymers 65 (3), pp. 337-345 (2006)
1.68
Shen L-F, Zhang Y-D, Shen H-J, Zeng S, Wang X, Wang C, Le Y, Shen H Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice Chinese Medical Journal 119 (15), pp. 1287-1293 (2006)
1.69
Bertholon I. Vauthier C, Labarre D, Complement activation by core-shell poly(isobutylcyanoacrylate)- polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide Pharmaceutical Research 23 (6), pp. 1313-1323 (2006)
1.70
Saupe A, McBurney W, Rades T, Hook S, Immunostimulatory colloidal delivery systems for cancer vaccines Expert Opinion on Drug Delivery 3 (3), pp. 345-354 (2006)
1.71
You J-O, Peng, C-ACalcium-alginate nanopartides for nonviral gene delivery NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2005 Technical Proceedings, pp. 270-273 (2005)
1.72
Soni S, Babbar AK, Sharma RK, Banerjee T, Maitra A, Pharmacoscintigraphic evaluation of polysorbate80-coated chitosan nanoparticles for brain targeting American Journal of Drug Delivery 3 (3), pp. 205-212 (2005)
1.73
Bala I, Bhardwaj V, Hariharan S, Sitterberg J, Bakowsky U, RaviKumar MNV Design of biodegradable nanoparticles: A novel approach to encapsulating poorly soluble phytochemical ellagic acid Nanotechnology 16 (12), pp. 2819-2822 (2005)
1.74
Boucard N, Viton C, Domard A New aspects of the formation of physical hydrogels of chitosan in a hydroalcoholic medium Biomacromolecules 6 (6), pp. 3227-3237 (2005)
